NCT03024437 2025-03-20Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell CarcinomaIndiana UniversityPhase 1/2 Terminated31 enrolled 19 charts
NCT02724878 2025-02-13Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell CarcinomaDana-Farber Cancer InstitutePhase 2 Completed65 enrolled 30 charts